Effect of transcatheter aortic valve implantation (TAVI) in acquired von Willebrand syndrome and molecular analysis of high-molecular-weight multimers.

Combination of pre-existing atrial fibrillation and coronary artery disease associates with poor outcome in patients who undergo TAVI

Transcatheter aortic valve replacement alters expression levels of circulating myocardial microRNAs

Cardiac biomarkers and clinical scores for risk stratification in patients with severe symptomatic aortic stenosis undergoing TAVI. Which ranks first now?

Peri-procedural myocardial injury depends on transcatheter heart valve type but does not predict mortality in patients after tavi

Impact of diastolic dysfunction severity on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement

Potential clinical utility of intraprocedural three-dimensional integrated image guided transcatheter aortic valve implantation using novel automated computed tomography software

Acquired intracardiac shunts following transcatheter aortic valve replacement

Long-term survival of low- and intermediate risk TAVI-patients: a real world, single center comparison of 684 patients treated with the sapien 3 or the sapien XT device.

Transcatheter aortic valve implantation in nonagenarians: long-term cohort analysis from a pioneered center.